Mission

Neurokin develops a new generation of neuroprotectants, NK molecules, to treat and prevent pathologies of the central nervous system inducing acute lesion of the cerebral tissue through apoptosis.

Neurokin focuses primarily on stroke, global ischemia following cardiac arrest and traumatic brain injury (TBI). Preventive neurological approaches such as for stroke post cardiac surgery and epilepsy induced by TBI are also in our focus.